Related Experiment Video
Updated: Apr 15, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome
Sekhar C Pillai1, Yael Hacohen2, Esther Tantsis1
1Neuroimmunology Group, Institute of Neuroscience and Muscle Research at the Kids Research Institute, Children's Hospital at Westmead, University of Sydney, Australia; TY Nelson Department of Neurology and Neurosurgery and.
Insights
Pediatric encephalitis classification revealed immune-mediated/autoantibody-associated forms are common. Early recognition and treatment of these and other encephalitis types are crucial for better patient outcomes.
Area of Science:
- Pediatric Neurology
- Neuroimmunology
- Infectious Diseases
Background:
- Pediatric encephalitis presents with diverse causes, clinical features, and prognoses.
- Classifying encephalitis is crucial for targeted treatment and improved outcomes.
Purpose of the Study:
- To classify and characterize infectious, immune-mediated/autoantibody-associated, and unknown forms of pediatric encephalitis.
- To determine the relative frequencies, clinical/radiologic phenotypes, and long-term outcomes of different encephalitis types.
Main Methods:
- Retrospective analysis of 164 Australian children with encephalitis using consensus definitions.
- Clinical and radiologic phenotyping blinded to etiology; archived sera tested for specific autoantibodies.
- Long-term outcomes assessed via telephone interviews using the Liverpool Outcome Score.
Main Results:
- Immune-mediated/autoantibody-associated encephalitis accounted for 34% of cases; infectious encephalitis for 30%.
- Key subgroups included acute disseminated encephalomyelitis (21%), enterovirus (12%), and N-methyl-D-aspartate receptor antibody (6%).
- Abnormal outcomes occurred in 49% of patients, with herpes simplex virus and unknown forms having the worst prognoses.
Conclusions:
- Defined clinical and radiologic phenotypes for infectious and immune-mediated/autoantibody-associated encephalitis in children.
- Immune-mediated/autoantibody-associated encephalitis is a frequent and critical diagnosis requiring prompt recognition and management.
- Status epilepticus, MRI diffusion restriction, and ICU admission were associated with poorer outcomes.
Background And Objectives:
Pediatric encephalitis has a wide range of etiologies, clinical presentations, and outcomes. This study seeks to classify and characterize infectious, immune-mediated/autoantibody-associated and unknown forms of encephalitis, including relative frequencies, clinical and radiologic phenotypes, and long-term outcome.
Methods:
By using consensus definitions and a retrospective single-center cohort of 164 Australian children, we performed clinical and radiologic phenotyping blinded to etiology and outcomes, and we tested archived acute sera for autoantibodies to N-methyl-D-aspartate receptor, voltage-gated potassium channel complex, and other neuronal antigens. Through telephone interviews, we defined outcomes by using the Liverpool Outcome Score (for encephalitis).
Results:
An infectious encephalitis occurred in 30%, infection-associated encephalopathy in 8%, immune-mediated/autoantibody-associated encephalitis in 34%, and unknown encephalitis in 28%. In descending order of frequency, the larger subgroups were acute disseminated encephalomyelitis (21%), enterovirus (12%), Mycoplasma pneumoniae (7%), N-methyl-D-aspartate receptor antibody (6%), herpes simplex virus (5%), and voltage-gated potassium channel complex antibody (4%). Movement disorders, psychiatric symptoms, agitation, speech dysfunction, cerebrospinal fluid oligoclonal bands, MRI limbic encephalitis, and clinical relapse were more common in patients with autoantibodies. An abnormal outcome occurred in 49% of patients after a median follow-up of 5.8 years. Herpes simplex virus and unknown forms had the worst outcomes. According to our multivariate analysis, an abnormal outcome was more common in patients with status epilepticus, magnetic resonance diffusion restriction, and ICU admission.
Conclusions:
We have defined clinical and radiologic phenotypes of infectious and immune-mediated/autoantibody-associated encephalitis. In this resource-rich cohort, immune-mediated/autoantibody-associated etiologies are common, and the recognition and treatment of these entities should be a clinical priority.
Related Concept Videos
Arboviral Encephalitis
Endocarditis II: Clinical Features of Infective Endocarditis
Viral Meningitis
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Myocarditis II: Clinical Features and Diagnostic Tests

